These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20186457)

  • 1. A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis.
    Morimoto S; Takahashi N; Someya K; Morita T; Jo F; Toyoda N; Kosaki A; Nishikawa M; Iwasaka T
    Clin Exp Nephrol; 2010 Aug; 14(4):363-6. PubMed ID: 20186457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathy.
    Takada D; Mii A; Higo S; Obara Y; Kurabayashi Y; Kurosawa N; Miura S; Kawachi H; Shimizu A
    CEN Case Rep; 2012 May; 1(1):16-23. PubMed ID: 28509154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.
    van Hoeck KJ; Rusthoven E; Vermeylen L; Vandesompel A; Marescau B; Lilien M; Schroder CH
    Nephrol Dial Transplant; 2003 Jul; 18(7):1383-7. PubMed ID: 12808177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study.
    Rodríguez-Carmona A; Pérez Fontán M; García López E; García Falcón T; Díaz Cambre H
    Perit Dial Int; 2007; 27(3):260-6. PubMed ID: 17468473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with icodextrin. Multicenter study].
    Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
    Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.
    Johnson DW; Arndt M; O'Shea A; Watt R; Hamilton J; Vincent K
    BMC Nephrol; 2001 Dec; 2():2. PubMed ID: 11737871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icodextrin and peritoneal dialysis: advantages and new applications.
    Dousdampanis P; Musso CG; Trigka K
    Int Urol Nephrol; 2018 Mar; 50(3):495-500. PubMed ID: 28674854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the use of icodextrin in peritoneal dialysis patients.
    Johnson DW; Agar J; Collins J; Disney A; Harris DC; Ibels L; Irish A; Saltissi D; Suranyi M
    Nephrology (Carlton); 2003 Feb; 8(1):1-7. PubMed ID: 15012742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis.
    Rousso S; Banh TM; Ackerman S; Piva E; Licht C; Harvey EA
    Pediatr Nephrol; 2016 Oct; 31(10):1673-9. PubMed ID: 27178072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icodextrin produces higher ultrafiltration in diabetic than in non-diabetic patients on continuous cyclic peritoneal dialysis.
    Ahmad M; Jeloka T; Pliakogiannis T; Tapiawala S; Zhong H; Bargman JM; Oreopoulos D
    Int Urol Nephrol; 2008; 40(1):219-23. PubMed ID: 17990071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of peritoneal ultrafiltration in the elderly refractory congestive heart failure patients.
    Ruhi Ç; Koçak H; Yavuz A; Süleymanlar G; Ersoy FF
    Int Urol Nephrol; 2012 Jun; 44(3):963-9. PubMed ID: 22388751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring new evidence of the clinical benefits of icodextrin solutions.
    Davies SJ
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii47-50. PubMed ID: 16825261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients.
    Furuya R; Odamaki M; Kumagai H; Hishida A
    Nephrol Dial Transplant; 2006 Feb; 21(2):494-8. PubMed ID: 16221697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icodextrin: fifteen years and counting. Introduction.
    Blake PG
    Perit Dial Int; 2009; 29(4):367-9. PubMed ID: 19725196
    [No Abstract]   [Full Text] [Related]  

  • 17. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities.
    Fourtounas C; Hardalias A; Dousdampanis P; Papachristopoulos B; Savidaki E; Vlachojannis JG
    Adv Perit Dial; 2008; 24():27-31. PubMed ID: 18985997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falsely Elevated Glucose Concentrations in Peritoneal Dialysis Patients Using Icodextrin.
    Dogan K; Kayalp D; Ceylan G; Azak A; Senes M; Duranay M; Yucel D
    J Clin Lab Anal; 2016 Sep; 30(5):506-9. PubMed ID: 26511081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis for patients suffering from severe heart failure.
    Sotirakopoulos NG; Kalogiannidou IM; Tersi ME; Mavromatidis KS
    Clin Nephrol; 2011 Aug; 76(2):124-9. PubMed ID: 21762644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.